analysts at Canaccord authenticity Start of reporting on the specialty chemicals group Iofina on “Buy” on Monday as it indicated a “strong earnings profile going forward.”

Canaccord said Iofina’s vertical integration gave it a “significant cost advantage” over competing iodine suppliers, which are primarily based in Chile. It also said iodine has “attractive long-term growth characteristics” and is currently experiencing “significant supply shortages.”

“We expect this to continue well into 2023 and possibly…